Evaluation of health outcomes and cost-effectiveness of 13-valent Pneumococcal Conjugate Vaccination for infants in Kazakhstan

dc.contributor.authorBektur, C.R.
dc.contributor.authorNurgozhin, T.S.
dc.creatorC.R., Bektur
dc.date.accessioned2017-12-14T03:08:35Z
dc.date.available2017-12-14T03:08:35Z
dc.date.issued2015-08-01
dc.identifierDOI:10.1016/j.clinthera.2015.05.219
dc.identifier.citationC.R. Bektur, T.S. Nurgozhin, Evaluation of health outcomes and cost-effectiveness of 13-valent Pneumococcal Conjugate Vaccination for infants in Kazakhstan, In Clinical Therapeutics, Volume 37, Issue 8, Supplement, 2015, Page e76
dc.identifier.issn01492918
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0149291815005263
dc.identifier.urihttp://nur.nu.edu.kz/handle/123456789/2879
dc.relation.ispartofClinical Therapeutics
dc.rights.licenseCopyright © 2015 Published by Elsevier Inc.
dc.titleEvaluation of health outcomes and cost-effectiveness of 13-valent Pneumococcal Conjugate Vaccination for infants in Kazakhstan
dc.typeArticle
dcterms.publisherClinical Therapeutics
elsevier.aggregationtypeJournal
elsevier.coverdate2015-08-01
elsevier.coverdisplaydateAugust 2015
elsevier.identifier.doi10.1016/j.clinthera.2015.05.219
elsevier.identifier.eid1-s2.0-S0149291815005263
elsevier.identifier.piiS0149-2918(15)00526-3
elsevier.issue.identifier8
elsevier.issue.nameThe Proceedings of the 12th Congress of the European Association for Clinical Pharmacology and Therapeutics
elsevier.openaccess0
elsevier.openaccessarticlefalse
elsevier.openarchivearticlefalse
elsevier.startingpagee76
elsevier.volume37

Files

Collections